Centralized procurement of Chinese patent medicines in 19 places including Hubei and Hebei started!

On September 25, the Hubei Provincial Pharmaceutical Price and Bidding Procurement Management Service Network issued the "Announcement of Centralized Procurement of Proprietary Chinese Medicines by the Interprovincial Alliance (No.

The original text is as follows:

Announcement of Centralized Procurement of Chinese Patent Medicine Interprovincial Alliance

(No.

In order to further promote the reform of centralized drug procurement, in accordance with the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Drug Centralized Procurement" (Guobanfa [2021] No.

1.

The centralized procurement of Chinese patent medicines is a Chinese patent medicine produced by many companies with a large amount of clinical use and a high purchase amount

Second, the scope of procurement execution

All public medical institutions in the alliance area (including military medical institutions, the same below) should participate, and medical insurance designated social medical institutions and designated pharmacies are encouraged to participate in accordance with the relevant regulations of the alliance region

Three, apply for qualifications

Imported drugs designated by domestic drug manufacturers, drug marketing license holders, and drug marketing license holders (for overseas companies) that have obtained the legal qualifications of the products listed in the centralized procurement catalog of Chinese patent medicines and provide drugs and accompanying services The national general agent can participate as a declared enterprise

Four, procurement rules

(1) Agreed purchase quantity

The joint procurement organization organizes relevant companies to declare the product list, and the medical institution fills in the historical procurement volume and the pre-purchased volume, and summarizes the pre-purchased volume to form an agreed procurement volume according to a certain proportion

1.

2.

3.

(2) Competition unit

Within the same product group, it is divided into two competition units, A and B, which compete separately

1.

2.

If there are less than 3 declared companies entering the B competition unit, all the declared companies in the same product group will be merged into the A competition unit

(3) Quotation requirements

1.

2.
Base price
.
As of the date of this procurement announcement, all products of the declared enterprise shall have the lowest bid-winning / online price on the national provincial procurement platform (excluding the online price of the Guangdong procurement platform and the selected prices for centralized drug procurement in various provinces)
.
If the product has no bid-winning/online price on all provincial platforms across the country, the average daily treatment cost (calculated according to the usage and dosage stated in the manual) for all the representative products quoted in the same competition unit, regardless of the difference in dosage form specifications, is as follows: Same) The lowest converted price is used as the base price
.

3.
Declare the price
.
The declared price is the actual supply price of the smallest retail package of the quotation representative product, and should include all costs such as taxes, normal delivery and accompanying services
.
If the declared price is not higher than the benchmark price, it is a valid quotation; if the declared price is zero, the declared price is higher than the benchmark price, and the quotation is not completed within the specified time, it shall be deemed as an invalid quotation
.
The declared price shall be reported in RMB, the unit shall be "yuan", and it shall be kept to 2 decimal places
.

(4) Finalist rules

1.
Finalist competition rules

The finalists were selected based on the decline in the quotation representative products and the comprehensive scores of medical institution recognition, corporate ranking, supply capacity, innovation ability, recruitment credit rating, drug quality and safety and other factors
.

(1) Price competition score: Declaring companies declare prices based on the representative products of the quotation, and determine the price competition score based on the decrease in the declared price
.
The price competition score of the declared enterprises with invalid quotations is "0"
.
The specific calculation formula is:

(2) Technical evaluation score: According to the technical evaluation index and score table, assign scores to the applying enterprise
.

Technical evaluation index and score table (total score 100 points)

2.
The number of shortlisted companies is the same as the competition unit, and the shortlisted companies are determined according to the comprehensive score of the declared companies from high to low
.
See the table below for the number of shortlisted companies in the same competition unit
.

Number of finalists in the same competition unit

When the comprehensive scores of the declared companies are the same, the finalists will be determined in turn according to the following conditions:

① Enterprises with a large price drop in the declared price will be given priority;

②Enterprises with a large number of procurement requirements reported by medical institutions in the alliance area are preferred;

③ Enterprises with a large number of procurement requirements reported by tertiary medical institutions in the alliance area are preferred
.

(5) Proposed selection rules

1.
Sort the quotations of the finalists in the A competition unit of the 17 product groups from high to low, and the top 70% of the companies (rounded up, the same below) will directly qualify for the proposed selection; if the bottom declines are the same, Then they will be eligible to be selected
.
The lower 30% of the companies in the ranking of the decline will enter the bargaining session and accept the median decline of the finalists in all A competition units of the 17 product groups (50% of the ranking decline, the same below), and obtain the qualification for the proposed selection
.

2.
In the B competition unit, if the number of shortlisted companies is more than 4, the shortlisted companies will be directly eligible to be selected
.
If the number of shortlisted companies is less than or equal to 4, the price drop of the shortlisted companies will reach the lowest drop of the top 70% of the top 70% of the top-ranked companies in all A competition units of the 17 product groups, and they will be eligible for the proposed selection; those that have not reached the bargaining process will enter the bargaining process and accept 17 product groups The median rate of the shortlisted companies in all A competition units dropped and they were eligible to be selected
.

3.
Supplement the selected enterprises
.
After determining the company to be selected according to the above rules, the applicant company that is not shortlisted or not selected, whose representative product is the lowest average daily treatment cost in the same product group, can be eligible for the selection
.
If the average daily treatment cost of the quotation representative product is the same, the one with the higher comprehensive score will be eligible to be selected
.

4.
After the companies to be selected for each product group are produced, the declared price of the representative product of the company to be selected or the negotiated price accepted is the proposed price of the quotation representative product; the other products in the product list of the company are adjusted downward in proportion to the decrease of the representative product of the quotation Price, forming the proposed selected price for non-quotation representative products, the specific calculation formula is:

Both the quotation representative products and the non-quotation representative products to be selected are regarded as the selected products and participate in the allocation of procurement volume
.

(6) Allocation of agreed purchase quantity

After the proposed company has announced that there is no objection, its proposed product is determined to be the selected product, and the agreed procurement volume allocation rules are:

1.
If the product for which a medical institution fills in the procurement requirements is in the selected range, the selected product in the same bidding unit with the highest drop (calculated by the reduction in the shortlisted quotation, the same below) will be allocated to the corresponding medical institution according to the agreed purchase volume; other selected products will be 90% The agreed procurement volume is allocated to the corresponding medical institution
.

2.
Pharmaceutical institutions fill in the procurement requirements but are not in the selected range, have not declared by the company, and fill in the agreed procurement volume of products with a production capacity of "0", and the agreed procurement volume of the selected products that has not been allocated as the amount to be allocated, and the pharmaceutical institution shall follow the following order Allocation: ①Allocate 30% of the amount to be allocated to the selected enterprise with the highest decline in the same product group; ②The remaining 70% of the amount to be allocated is independently selected by the medical institution from all the products of the selected enterprise
.

3.
In order to ensure supply, when the selected amount of medical institutions exceeds 80% of the maximum production capacity of each selected product, medical institutions will no longer be open to select the product, and medical institutions can continue to select other selected products
.

Five, procurement cycle

In principle, the procurement cycle for the centralized procurement of Chinese patent medicines is 2 years, and it will be calculated from the actual implementation date of the selection results
.
The purchase agreement is signed every year during the purchase cycle.
If the agreed purchase amount of the year is completed in advance during the purchase cycle, the selected companies will still supply the selected companies at the selected price until the end of the purchase cycle
.

6.
Related work arrangements

Log in to the Hubei Medical Insurance Service Platform (http://ybj.
hubei.
gov.
cn/hubeiHallSt/web/hallEnter/#/Index) for the registered account and password of the applying company.
After the login is successful, fill in the product qualification and production capacity on the Chinese patent medicine qualification enterprise application interface For details, please refer to the operation manual for specific operation methods
.

The opening hours of the system are: September 27, 2021, from 9 o'clock to October 8th, 17:00
.
Enterprises participating in the declaration must respond within the specified time
.
After the system is shut down, no new additions, deletions or changes to relevant information will be accepted
.

Seven, contact information

Contact number: 027-87265910 (policy consultation), 027-87265911 (system operation)
.

QQ group for collection and exchange of proprietary Chinese medicines: 435792367
.

Service hours: 9:00-12:00, 14:30-17:30, except holidays
.

Other unmentioned matters will be announced separately
.

Central Procurement Leading Group Office of the Inter-Provincial Alliance of Chinese Patent Medicine

September 25, 2021